Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Effect of SGLT2 inhibitors on anemia and their possible clinical implications Aleix Cases; Secundino Cigarrán; José Luis Górriz; Julio Nuñez;

Burden and challenges of heart failure in patients with chronic kidney disease. A call to action Gregorio Romero-González; Susana Ravassa; Omar González; Ignacio Lorenzo; Miguel Angel Rojas; Isabel García-Trigo; Nuria García-Fernández; Javier Lavilla; Paloma L. Martín; Begoña López; Arantxa González; Francisco J. Beaumont; Gorka San José; María U. Moreno; Noelia Ania; Elena Osacar; Pilar Amézqueta; Javier Díez;